Literature DB >> 33402530

Measuring the subcellular compartmentalization of viral infections by protein complementation assay.

Juliette Fernandez1, Cédric Hassen-Khodja2, Virginie Georget2, Thierry Rose3, Yves Jacob4, Yves L Janin5, Sébastien Nisole1, Pierre-Olivier Vidalain6,7, Nathalie J Arhel8.   

Abstract

The recent emergence and reemergence of viruses in the human population has highlighted the need to develop broader panels of therapeutic molecules. High-throughput screening assays opening access to untargeted steps of the viral replication cycle will provide powerful leverage to identify innovative antiviral molecules. We report here the development of an innovative protein complementation assay, termed αCentauri, to measure viral translocation between subcellular compartments. As a proof of concept, the Centauri fragment was either tethered to the nuclear pore complex or sequestered in the nucleus, while the complementary α fragment (<16 amino acids) was attached to the integrase proteins of infectious HIV-1. The translocation of viral ribonucleoproteins from the cytoplasm to the nuclear envelope or to the nucleoplasm efficiently reconstituted superfolder green fluorescent protein or NanoLuc αCentauri reporters. These fluorescence- or bioluminescence-based assays offer a robust readout of specific steps of viral infection in a multiwell format that is compatible for high-throughput screening and is validated by a short hairpin RNA-based prototype screen.

Entities:  

Keywords:  subcellular compartments; technological development; viruses

Mesh:

Substances:

Year:  2021        PMID: 33402530      PMCID: PMC7812837          DOI: 10.1073/pnas.2010524118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating.

Authors:  Juliette Fernandez; Anthony K Machado; Sébastien Lyonnais; Célia Chamontin; Kathleen Gärtner; Thibaut Léger; Corinne Henriquet; Camille Garcia; Débora M Portilho; Martine Pugnière; Laurent Chaloin; Delphine Muriaux; Yohei Yamauchi; Mickaël Blaise; Sébastien Nisole; Nathalie J Arhel
Journal:  Nat Microbiol       Date:  2019-10-14       Impact factor: 17.745

3.  Degradation of HIV-1 integrase by the N-end rule pathway.

Authors:  L C Mulder; M A Muesing
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

4.  Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

Authors:  Renate König; Yingyao Zhou; Daniel Elleder; Tracy L Diamond; Ghislain M C Bonamy; Jeffrey T Irelan; Chih-Yuan Chiang; Buu P Tu; Paul D De Jesus; Caroline E Lilley; Shannon Seidel; Amanda M Opaluch; Jeremy S Caldwell; Matthew D Weitzman; Kelli L Kuhen; Sourav Bandyopadhyay; Trey Ideker; Anthony P Orth; Loren J Miraglia; Frederic D Bushman; John A Young; Sumit K Chanda
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

5.  Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus -1 preintegration complex (DNA).

Authors:  Ruonan Zhang; Rajeev Mehla; Ashok Chauhan
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

6.  TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm.

Authors:  Alberto De Iaco; Federico Santoni; Anne Vannier; Michel Guipponi; Stylianos Antonarakis; Jeremy Luban
Journal:  Retrovirology       Date:  2013-02-15       Impact factor: 4.602

Review 7.  Nuclear trafficking of retroviral RNAs and Gag proteins during late steps of replication.

Authors:  Matthew S Stake; Darrin V Bann; Rebecca J Kaddis; Leslie J Parent
Journal:  Viruses       Date:  2013-11-18       Impact factor: 5.048

8.  Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.

Authors:  Matthew D J Dicks; Gilberto Betancor; Jose M Jimenez-Guardeño; Lucie Pessel-Vivares; Luis Apolonia; Caroline Goujon; Michael H Malim
Journal:  PLoS Pathog       Date:  2018-11-29       Impact factor: 6.823

9.  Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.

Authors:  Alberto De Iaco; Jeremy Luban
Journal:  Retrovirology       Date:  2014-01-30       Impact factor: 4.602

10.  Nuclear pore blockade reveals that HIV-1 completes reverse transcription and uncoating in the nucleus.

Authors:  Adarsh Dharan; Niklas Bachmann; Sarah Talley; Virginia Zwikelmaier; Edward M Campbell
Journal:  Nat Microbiol       Date:  2020-06-01       Impact factor: 30.964

View more
  1 in total

1.  Lighting the way to host-directed immunotherapeutics.

Authors:  Sarah van Tol; Adam Hage; Ricardo Rajsbaum
Journal:  Cell Chem Biol       Date:  2022-07-21       Impact factor: 9.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.